– Interview with Owen Witte, M.D., Researcher, UCLA Jonsson Cancer Center, and a Howard Hughes Medical Institute Investigator

Previous articleVeridex to Acquire Immunicon Assets for $31M
Next articleAmVac and Bayer to Develop Novel Production Process for Flu Vaccine